Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Naming Prescription Drugs: Navigating Regulatory And Trademark Challenges

Choosing a "brand name" for prescription drugs in Canada is not just about creativity or marketing appeal – it is a careful balance between legal and regulatory requirements.

ML

McMillan LLP

No Cherry Picking Here: Canadian Cherry Patent Victory In U.S. Agribusiness Intellectual Property Case

In a major legal win for Canadian agribusiness innovation, Agriculture and Agri-Food Canada (AAFC) has successfully defended its intellectual property rights in the United States over the Staccato cherry, a late-ripening variety developed in Summerland, British Columbia.

F

Fasken

CFIA Reinforces Accuracy In "Product Of Canada" And "Made In Canada" Claims

As the trade war continues to impact the purchasing decisions of Canadian consumers, the market has seen a surge in "Canadiana"—from the iconic maple leaf mark to claims such as "Made in Canada", "Product of Canada"...

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada To Modernize Biologic Drug Submissions

Health Canada has made two announcements aimed at modernizing and streamlining submissions for biologic drugs, for both biosimilars and innovative biologic drugs.

Canada Healthcare

TL

Torys LLP

Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques

MT

McCarthy Tétrault LLP

Important Changes To The Exception Patient Measure In Quebec

Canada Healthcare

F

Fasken

Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime

MT

McCarthy Tétrault LLP

Patented Medicine Prices Review Board Publishes New Guidelines For PMPRB Staff: Finally, Some Guidance For Patentees

BL

Borden Ladner Gervais LLP

Les nouvelles lignes directrices du CEPMB sont enfin disponibles

Canada Healthcare

FF

Fasken (French)

The Court Grants An Appeal In Favour Of Psychedelic Assisted Psychotherapy – Toth v. Canada, 2025 FCA 119

Canada Healthcare

ML

McMillan LLP

Patents And Prior Art: Federal Court Clarifies Standards For Anticipation And Obviousness

AB

Aird & Berlis LLP

2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Important New Procedural Guidelines From The PMPRB

AM

Aird & McBurney LP

Final Guidelines From Canada's PMPRB: The New Era Begins

TL

Torys LLP

How CRA Conducts Net Worth Audits And Enforces Gross Negligence Penalties Against Canadian Taxpayers: Lessons From Mann v. The King And Other Cases

RS

Rotfleisch & Samulovitch P.C.

Powering Innovation: Updates On New And Clean Technology Interconnection Issues In Alberta And Ontario

C

Cassels

How Are Professional Poker Winnings Taxed In Canada? Taxable Business Income And Non-Taxable Hobbies: Fournier-Giguère V. Canada Et. Al., 2025 FCA 112

RS

Rotfleisch & Samulovitch P.C.

Canadian Intellectual Property Office "Next Generation Patents" Update And Status As Of May 13, 2025

SB

Smart & Biggar

Powering The Future: Canada's Leadership In Nuclear Energy & Small Modular Reactors

MA

MLT Aikins LLP

The Trademark Four(Mula): Enforcement And Risk Mitigation

Trademarks are important assets for any business. When it comes to trademark enforcement, options abound, which can sometimes be disorienting for the uninitiated.

OH

Osler, Hoskin & Harcourt LLP

Q&A On Managing Intergenerational Growth In Canadian Agribusiness

Canadian agricultural family enterprises are living legacies that anchor our local economies. From household names to community-driven farms, these businesses have deep...

Canada Real Estate

BJ

Bennett Jones LLP

July 2025 Rosen Sunshine Newsletter

Our July 2025 newsletter is out. In this issue...

Canada Government

RS

Rosen Sunshine LLP

Finalized PMPRB Guidelines Published

On June 30, 2025, the Patented Medicine Prices Review Board (PMPRB) published its new Guidelines for PMPRB Staff, which will come into force on January 1, 2026.

SB

Smart & Biggar

At Long Last: The New PMPRB Guidelines Are Here

Worldwide Healthcare

F

Fasken

CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary

Canada Healthcare

SB

Smart & Biggar

North Of Legal Or South Of Safe? Key Legal And Regulatory Considerations To Substantiate "Made In Canada" Claims

Canada Healthcare

LS

Lenczner Slaght LLP

CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025

Canada Healthcare

F

Fasken

Health Canada's New Draft Guidance For Biosimilar Biologic Drugs

Canada Healthcare

F

Fasken

Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training

Canada Healthcare

SB

Smart & Biggar

Pharma, National Security And Tariffs: Where Do We Go From Here?

Canada Healthcare

BL

Borden Ladner Gervais LLP

Psychedelic Appeal: FCA Rules That Government Must Explain Policy Change On Psilocybin Access

Canada Healthcare

TL

Torys LLP

Update On Biosimilars In Canada – June 2025

Canada Healthcare

SB

Smart & Biggar

Travel Insurance And Alcohol: What Every Canadian Needs To Know

Canada Litigation

Wallace Smith LLP

Pharma, National Security And Tariffs: Where Do We Go From Here?

After the tariff frenzy of the first quarter of this year, we've sailed into the doldrums. Not that the tariffs have gone away, or the threat of new ones has subsided, or there is a solid prospect...

Canada Healthcare

BL

Borden Ladner Gervais LLP

Psychedelic Appeal: FCA Rules That Government Must Explain Policy Change On Psilocybin Access

As science evolves, policies may evolve as well. But when policy changes affect how a decision-maker exercises their discretion, those decision-makers must explain why they are taking a new approach.

Canada Healthcare

TL

Torys LLP

Update On Biosimilars In Canada – June 2025

This article provides an update on developments in the biosimilar space in Canada—regulatory, approvals, pending submissions, litigation, and market access—since our March 2024 update.

Canada Healthcare

SB

Smart & Biggar

Travel Insurance And Alcohol: What Every Canadian Needs To Know

For many Canadians, vacation time means escaping the cold, and for some, that also means enjoying a drink or two.

Canada Litigation

Wallace Smith LLP

La nouvelle ébauche de la Ligne directrice de Santé Canada sur les médicaments biologiques biosimilaires

Canada Healthcare

FF

Fasken (French)

Drug And Alcohol Testing In Canada: SCC Denies Leave To Appeal In Power Workers' Union v. Canada

On May 29, 2025, the Supreme Court of Canada (SCC) dismissed an application for leave to appeal from the decision of the Federal Court of Appeal (FCA) upholding drug and alcohol testing requirements...

Canada Employment

BL

Borden Ladner Gervais LLP

Apotex Not Entitled To Damages For Delayed Generic Drug Launch

The Ontario Court of Appeal's recent decision in Apotex Inc. v. Eli Lilly and Company offers important clarity for pharmaceutical companies engaged in patent litigation under the Patented Medicines (Notice of Compliance) Regulations ("NOC Regulations").

TS

Tierney Stauffer LLP

CDA Update: New Five-Year Strategic Plan And Position Statement On Using AI In Health Technology Assessments

On April 15, 2025, Canada's Drug Agency (CDA) released its new five-year strategic plan, Insight to Impact 2025-2030. Formerly the Canadian Agency for Drugs and Technologies in Health (CADTH), this is the CDA's first strategic plan.

Canada Healthcare

SB

Smart & Biggar

Sector Snapshot: Private Equity Increasingly Hungry For Food And Beverage Industry Deals

Private equity investment in the food and beverage industry continues to steadily increase, driven in part by evolving consumer preferences and a heightened focus on sustainability.

Canada Healthcare

BJ

Bennett Jones LLP

Alexion Awarded Injunction Against Amgen In SOLIRIS Patent Action; Court Considers Anticipation By Incorporation By Reference

SB

Smart & Biggar

CBSA Guidance Seeks To Narrow Scope Of Relief From Canada's Retaliatory Tariffs

Canada International

MT

McCarthy Tétrault LLP

How Do I Get Out Of This? New Guidance On Eligibility For Tariff Remissions And Support Programs For Canadian Businesses

Canada International

BJ

Bennett Jones LLP

Court Of Appeal Cuts Off Speculative Product Liability Claims

Canada Litigation

BJ

Bennett Jones LLP

Government Of Ontario Tables Budget 2025: A Plan To Protect Ontario

Worldwide Strategy

GW

Gowling WLG

Episode 76: Scaling Impact Through Entrepreneurship In Food And Hospitality (Podcast)

Canada Commercial

D

Dentons

Arbitrator Rejects "Lowest-Cost Generic" Policy For Generic Substitutes In Collective Bargaining Agreement

Canada Employment

C

Cassels

Court Finds Eculizumab Patent Neither Anticipated Nor Obvious

AK

Aitken Klee

Landlords May Soon Need To Be On (Top Of) Drugs: Unpacking Ontario's Bill 10

Canada Real Estate

RA

Robins Appleby LLP

Mandatory Front-of-package Labelling Compliance By 2026 — Are You Prepared?

Canada Healthcare

BL

Borden Ladner Gervais LLP

A Guide To Commercial Patriotism: Understanding 'Made In Canada' And Similar Labels

Canada Anti-trust

AB

Aird & Berlis LLP

5 Key Trends Shaping The Life Sciences Industry (Video)

Canada Healthcare

RS

RSM Canada

Licensing Partnerships In Life Sciences: Emerging And Expected Trends In 2025

Canada Healthcare

GW

Gowling WLG

Instruments médicaux basés sur l'IA — Transformation et réglementation

Canada Healthcare

MT

McCarthy Tétrault LLP

Some Things Last Forever: Government Of Canada Proposes Regulatory Measures For PFAS

Canada Environment

OH

Osler, Hoskin & Harcourt LLP

See more

Latest Videos

See more

Drug Pricing And Reimbursement: The Role Of Provinces And Hospitals In Pharmaceutical Pricing (Video)

TL

Torys LLP

Nutrition Tips & Advice During COVID-19 (Video)

GW

Gowling WLG

What Are The Challenges And Opportunities In Ontario's Budding Cannabis Retail Market? (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Two: Weed Growth (Video)

D

Dentons

2018 Legal Year In Review (Video)

OH

Osler, Hoskin & Harcourt LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More